At a time when a particularly large number of drugs are being tested in studies, such as the current COVID 19 pandemic, the number of different primary packaging is increasing. This is because the large number of different ampoule and vial sizes requires new packaging designs time and again. "For many manufacturers, this is a rather tiresome and cost-intensive issue. What's more, the different types of packaging take up a lot of storage space," says Joachim Hoeltz, Chief Executive Officer Packaging Materials in the Körber Business Area Pharma. "Our long-standing customer UCB therefore approached us with the idea of finding a sustainable solution to this issue together.